|
2022
|
Invention
|
Biofilm prevention, disruption and treatment with bacteriophage lysin.
The present invention pro... |
|
|
Invention
|
Method of treating and preventing bone and joint infections. The present disclosure is directed t... |
|
|
Invention
|
New uses. StaphylococcusStaphylococcusStaphylococcus Staphylococcus infection. |
|
|
Invention
|
Plyss2 lysins and variants thereof for use against multidrug resistant gram-positive bacteria. Di... |
|
|
Invention
|
Amurins, lysins, and lysin-antimicrobial peptide (amp) constructs active against gram-negative ba... |
|
|
Invention
|
Amurins lysins, and lysin-antimicrobial peptide (amp) constructs active against gram-negative bac... |
|
2021
|
Invention
|
Antibodies useful in passive influenza immunization, and compositions, combinations and methods f... |
|
|
Invention
|
Modified plyss2 lysins and antibiotic combinations for use against gram-positive bacteria.
Discl... |
|
|
Invention
|
Modified plyss2 lysins and antibiotic combinations for use against gram-positive bacteria. Disclo... |
|
|
Invention
|
Antiviral, bacteriophage-derived polypeptides and their use against viruses. Disclosed herein are... |
|
|
Invention
|
Bacteriophage lysin and antibiotic combinations against gram positive bacteria.
The present inve... |
|
2020
|
Invention
|
Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in treating endocar... |
|
|
Invention
|
Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encodi... |
|
|
Invention
|
Therapeutic protein formulations comprising antibodies and uses thereof.
The present disclosure ... |
|
|
Invention
|
Therapeutic protein formulations comprising antibodies and uses thereof. The present disclosure i... |
|
|
Invention
|
Lysin polypeptides active against gram-negative bacteria. Pseudomonas aeruginosa. The disclosure ... |
|
|
Invention
|
Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative and acid-fa... |
|
|
Invention
|
Method of treating and preventing bone and joint infections.
The present disclosure is directed ... |
|
|
Invention
|
Lysins and derivatives thereof with bactericidal activity against pseudomonas aeruginosa, in the ... |
|
|
Invention
|
Pseudomonas aeruginosa, in the presence of human serum. P. aeruginosaP. aeruginosa, pharmaceutica... |
|
|
Invention
|
Method of treating infective endocarditis.
The present disclosure is directed to a method of tre... |
|
|
Invention
|
Method of treating infective endocarditis. The present disclosure is directed to a method of trea... |
|
2019
|
Invention
|
Compositions and methods comprising lysocins as bioengineered antimicrobials for use in targeting... |
|
|
Invention
|
Lysin cf-301 resensitizes methicillin-resistant staphylococcus aureua (mrsa) to penicillin deriva... |
|
|
Invention
|
Lysins and derivatives thereof resensitize staphylococcus aureus and gram-positive bacteria to an... |
|
|
Invention
|
Biofilm prevention, disruption and treatment with bacteriophage lysin. Staphylococcus aureus, par... |
|
|
Invention
|
Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria.
... |
|
|
Invention
|
Gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucl... |
|
|
Invention
|
Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria. D... |
|
|
Invention
|
Modified plyss2 lysins and uses thereof.
Disclosed herein are modified lysin polypeptides thereo... |
|
2018
|
Invention
|
Blood component potentiation of lytic protein anti-bacterial activity and methods and uses thereo... |
|
2015
|
P/S
|
PRODUCT RESEARCH, AND NEW PRODUCT DEVELOPMENT SERVICES, ALL IN THE FIELDS OF INFECTIOUS DISEASES ... |
|
2012
|
P/S
|
Biological cells and reagents for scientific research, agricultural research, pharmaceutical rese... |
|
2011
|
P/S
|
scientific, pharmaceutical, medical, veterinary, agricultural and product research, and new produ... |
